Fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol
Case report
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This case report describes fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia that developed during danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (5)
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
- [Danazol-induced hepatitis with functional deficit of the C1 inhibitor] 2001
- [Spontaneous splenic rupture caused by spleen peliosis in a patient with autoimmune thrombocytopenic purpura treated with danazol] 2000
- Splenic peliosis with spontaneous splenic rupture in a patient with immune thrombocytopenia treated with danazol 1998
- [Autopsy findings of retroperitoneal cystic tumor and peliosis hepatis in lymphangiomyomatosis] 1997
Source provenance
- openalex
- last seen: 2026-05-10T10:41:41.225191+00:00
- pubmed
- last seen: 2026-10-08T21:59:07.256998+00:00
License: CC0
· commercial use OK